Zhangren Tu1, Xiaodie Chen1, Jiayu Li1, Yirong Zhou1, Dichen Chen1, Tao Gong2, Lin Ou-yang3, Di Guo4, and Xiaobo Qu1
1Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen, China, 2Departments of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, 3Medical Imaging of Southeast Hospital, Medical College of Xiamen University, Zhangzhou, China, 4School of Computer and Information Engineering, Xiamen University of Technology, Xiamen, China
Synopsis
Keywords: AI/ML Software, Data Processing
Motivation: Magnetic resonance spectroscopy (MRS) is a powerful tool for disease diagnosis, but one of its limitations is the lack of user-friendly processing software or platforms.
Goal(s): Developing an integrated platform that is easy to use, provides powerful hardware, and incorporates advanced processing algorithms.
Approach: CloudBrain-MRS is a cloud-based online platform that has been developed. The platform can be accessed through a web browser without requiring any program installation on the user's side, and it integrates advanced artificial intelligence algorithms.
Results: The platform supports: 1): Automatic statistical analysis to find biomarkers for diseases;2) Consistency verification between classic and artificial intelligence quantification algorithms; 3)Visualize results.
Impact: This is the first user-friendly cloud computing platform for in
vivo MRS with an artificial intelligence processing. The biomedical
researchers can do clinical research effectively, and it greatly reduces the
requirements for the technical skill of users.
Purpose
Magnetic Resonance Spectroscopy (MRS) shows remarkable advantages in the field of analysis of human metabolites. MRS spectrum is used to observe the signal intensity of metabolites or further infer their concentrations. Although the magnetic resonance vendors commonly provide basic functions of spectra preprocessing and metabolite quantification, the widespread clinical research of MRS is still limited due to the lack of easy-to-use processing software or platform.Cloud computing provides an easily accessible, flexible and scalable platform. Users need not worry about hardware maintenance and management, and thus, they can focus on innovation and core tasks. In this study, we propose CloudBrain-MRS, a cloud based platform for automated data preprocessing, quantification, and analysis of MRS data, as in Fig. 1. We have shared our cloud platform at MRSHub, providing free access and service for two years. Please visit https://mrshub.org/software_all/#CloudBrain-MRS or https://csrc.xmu.edu.cn/CloudBrain.html. Users can register an account or use our demo account (username: demo_csg, password: csg12345678!).Method
The
platform method module is primarily divided into two parts: one is platform
construction, which includes platform architecture, security, and privacy
aspects; the other is the implementation of the integrated model for MRS data
processing, which includes preprocessing, quantification, statistical analysis,
and consistency analysis of different methods.
Platform construction: CloudBrain-MRS adopts the browser/service (B/S) working model, which stands for a browser-request/server-response model. Fig. 2 displays the interactions between each part and the
libraries they depend on. For data secure transmission, the platform uses the
2048-bit Rivest Shamir-Adleman (RSA) algorithm to encrypt sensitive information
before transmission. For data storage security, the platform sets up a white
list of allowed ports to impose strict access restrictions on the database and
adds protection against distributed denial of service (DDOS) attacks.
Integrated processing: This
platform includes advanced processing algorithms, including deep learning1 denoising method ReLSTM2 and quantification method QNet3 , and the
mainstream quantification tool LCModel4. Users can batch preprocess and
quantify MRS data online via a browser. The platform also includes a
statistical analysis, consistency analysis and visualization module.Results
Up
to now, the platform currently supports reading RAW data from Philips, Siemens,
and GE, DICOM data from United Imaging and Siemens, and also supports LCModel’s
data format.
1) Statistical analysis: CloudBrain-MRS has developed a statistical analysis module that
automatically quantifies and analyzes data uploaded by users, as shown in Fig. 3.
The module uses LCModel to quantify data and an independent samples t-test or a
Mann-Whitney U-test to analyze whether there is a significant difference
between healthy individuals and patients. To analyze the metabolic
characteristics of disease, the platform provides several key metabolite
concentrations as references. In addition, users can add other indicators
according to their research needs for analysis.
2) Consistency analysis: To help users verify the reliability of the traditional
quantification method LCModel and artificial intelligence quantification method
QNet, CloudBrain-MRS provides a consistency analysis service that is currently
limited to healthy individuals, as shown in Fig. 3. This service has two
aspects. Firstly, a Bland-Altman analysis is conducted to evaluate the degree
of consistency between the two algorithms. Secondly, box plots of metabolite
concentrations are generated based on the normal concentration ranges5 in
healthy individuals to check the distribution of metabolite concentration
values.
3) Visualization: To
help users evaluate quantification results, CloudBrain-MRS has developed a
range of visualization tools. Users can view fitted spectra of QNet or LCModel,
as shown in Fig. 4a and Fig. 4b. Additionally, the platform extracts the fitted
results for each metabolite, as shown in Fig. 4c and Fig. 4d, which aids in
evaluating the contribution of each metabolite. Moreover, the platform utilizes
echarts technology to provide 3D visualization of every metabolite, enabling
users to have a comprehensive view of the fit results, as in Fig. 4e.Conclusion
We have developed CloudBrain-MRS, a cloud computing platform that leverages artificial intelligence and traditional algorithms to processing MRS signals. Users can perform batch preprocessing, quantification, and analysis of MRS data through a web browser without the need for environment installation or code compilation. In support of clinical research and diagnosis, we will enhance the analysis capabilities to generate examination reports using biomarkers and offer preliminary disease classification for reference by medical professionals. To validate the reliability of CloudBrain-MRS, we encourage more doctors and experts to try it out.Acknowledgements
See more details in the full-length
preprint: https://arxiv.org/abs/2306.11021. This work was supported in part by
the National Natural Science Foundation of China under grants 62122064,
61971361, and 61871341, Natural Science Foundation of Fujian Province of China
under grants 2023J02005 and 2021J011184, President Fund of Xiamen University
under grant 20720220063, and Xiamen University Nanqiang Outstanding Talents
Program. The authors thank China Mobile for providing cloud computing services
support. The authors thank Zhigang Wu, Liangjie Lin, and Jiazheng Wang from
Philips and Jiayu Zhu and Xijing Zhang from United Imaging for technical support.
The authors also thank Stephen W. Provencher for making LCModel public.
The correspondence should be sent to Prof. Xiaobo
Qu (Email: quxiaobo@xmu.edu.cn)
References
- Q. Yang et al.,
Physics-driven synthetic data learning for biomedical magnetic resonance: The
imaging physics-based data synthesis paradigm for artificial intelligence, IEEE Signal Process Mag. 40
(2023) 129–140.
-
D. Chen et al., Magnetic
resonance spectroscopy deep learning denoising using few in vivo data, IEEE Trans. Comput. Imaging 9
(2023) 448–458.
-
D. Chen et al., Magnetic
resonance spectroscopy quantification aided by deep estimations of imperfection
factors and overall macromolecular signal, arXiv
preprint arXiv:2306.09681 (2023).
-
S. W. Provencher, Estimation
of metabolite concentrations from localized in vivo proton NMR spectra, Magn. Reson. Med. 30 (1993) 672–679.
-
H. H. Lee et al., Intact
metabolite spectrum mining by deep learning in proton magnetic resonance
spectroscopy of the brain, Magn.
Reson. Med. 82 (2019) 33–48.